LD-2 disclosure · 1st Quarter - Report
ANZA THERAPEUTICS INC
Client
- Description
- Development and manufacture of vaccines
- Location
- * Undetermined
Registrant
- Description
- government relations
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
HR ____, Department of Defense Appropriations Act, 2009, Title IV, all provisions relating to development of vaccines and biological agent therapeutics.
LobbyistsJESSICA EGGIMANN · JOHN LITTLE · LETITIA WHITE · mr DAVID FREDERICK KILIAN · MARK KULUNGOWSKI · AMANDA KING
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense Threat Reduction Agency (DTRA)
Defense
HR ____ / S _____, National Defense Authorization Act, 2009, Title II, all provisions relating to development of vaccines and biological agent therapeutics.
LobbyistsJESSICA EGGIMANN · JOHN LITTLE · LETITIA WHITE · mr DAVID FREDERICK KILIAN · MARK KULUNGOWSKI · AMANDA KING
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense Threat Reduction Agency (DTRA)